Stifel Nicolaus Restarts Ocera Therapeutics (OCRX) at Buy

December 30, 2013 7:29 AM EST
Get Alerts OCRX Hot Sheet
Price: $2.10 -2.33%

Rating Summary:
    7 Buy, 0 Hold, 0 Sell

Rating Trend: Up Up

Today's Overall Ratings:
    Up: 30 | Down: 30 | New: 23
Trade OCRX Now!
Join SI Premium – FREE
Stifel Nicolaus reinstates Ocera Therapeutics (Nasdaq: OCRX) at Buy and price target of $19.

For an analyst ratings summary and ratings history on Ocera Therapeutics click here. For more ratings news on Ocera Therapeutics click here.

Shares of Ocera Therapeutics closed at $11.70 last Fridy.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories

Analyst PT Change, New Coverage

Related Entities


Add Your Comment